H. Seidel

1.9k total citations
45 papers, 499 citations indexed

About

H. Seidel is a scholar working on Surgery, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H. Seidel has authored 45 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Hematology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H. Seidel's work include Venous Thromboembolism Diagnosis and Management (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Platelet Disorders and Treatments (5 papers). H. Seidel is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Platelet Disorders and Treatments (5 papers). H. Seidel collaborates with scholars based in Germany, Norway and United States. H. Seidel's co-authors include Tor Skärby, Randi Nygaard, H. Anderson, Kjeld Schmiegelow, Jesper Heldrup, Jukka Kanerva, Angelika Eggert, Rüdiger E. Scharf, Peter Johan Moe and Md. Mostafizur Rahman and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and European Journal of Pharmacology.

In The Last Decade

H. Seidel

39 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Seidel Germany 14 161 112 109 108 79 45 499
Josef Häger Austria 9 40 0.2× 44 0.4× 53 0.5× 155 1.4× 21 0.3× 25 457
O’Neill Barrett United States 12 41 0.3× 24 0.2× 138 1.3× 91 0.8× 47 0.6× 28 507
Harriet Hédin Sweden 11 25 0.2× 25 0.2× 68 0.6× 71 0.7× 36 0.5× 23 502
H. Owen United States 9 38 0.2× 47 0.4× 112 1.0× 77 0.7× 30 0.4× 13 376
Thomas D. Beardmore United States 16 37 0.2× 65 0.6× 50 0.5× 137 1.3× 37 0.5× 24 711
Ryan J. Smith United States 14 170 1.1× 115 1.0× 37 0.3× 91 0.8× 14 0.2× 34 674
J. Scharf Israel 15 68 0.4× 13 0.1× 42 0.4× 87 0.8× 45 0.6× 36 460
Gökhan Koca Türkiye 15 31 0.2× 39 0.3× 82 0.8× 164 1.5× 6 0.1× 77 533
Jorge A. Alvarez United States 11 55 0.3× 113 1.0× 17 0.2× 155 1.4× 492 6.2× 14 694
Schmutz Jl France 12 29 0.2× 26 0.2× 25 0.2× 101 0.9× 9 0.1× 94 486

Countries citing papers authored by H. Seidel

Since Specialization
Citations

This map shows the geographic impact of H. Seidel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Seidel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Seidel more than expected).

Fields of papers citing papers by H. Seidel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Seidel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Seidel. The network helps show where H. Seidel may publish in the future.

Co-authorship network of co-authors of H. Seidel

This figure shows the co-authorship network connecting the top 25 collaborators of H. Seidel. A scholar is included among the top collaborators of H. Seidel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Seidel. H. Seidel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silaschi, Miriam, H. Seidel, Philipp Westhofen, et al.. (2024). Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay. Thrombosis Research. 241. 109094–109094. 1 indexed citations
2.
Homann, Jürgen, Martin Mücke, H. Seidel, et al.. (2022). Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome. Zeitschrift für Gastroenterologie. 61(3). 268–274. 2 indexed citations
3.
Seidel, H., et al.. (2020). Schmerztherapie bei Sichelzellkrankheit. Der Schmerz. 34(3). 285–296.
4.
Gundling, Felix, et al.. (2020). Small intestinal dysmotility in cirrhotic patients: correlation with severity of liver disease and cirrhosis-associated complications. Zeitschrift für Gastroenterologie. 59(6). 540–550. 1 indexed citations
5.
Bowyer, Annette, H. Seidel, Philipp Westhofen, et al.. (2018). Evaluation of a semi‐automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers. Research and Practice in Thrombosis and Haemostasis. 2(4). 790–799. 31 indexed citations
6.
7.
Polzin, Amin, H. Seidel, Rüdiger E. Scharf, et al.. (2015). High on-treatment platelet reactivity in transcatheter aortic valve implantation patients. European Journal of Pharmacology. 751. 24–27. 28 indexed citations
8.
Kolde, Hans-Jürgen, et al.. (2013). Multicentric validation of a rapid assay for heparin-induced thrombocytopenia with different specimen types. Blood Coagulation & Fibrinolysis. 25(1). 6–9. 6 indexed citations
9.
Rahman, Md. Mostafizur, H. Seidel, & Rüdiger E. Scharf. (2011). The impact and management of acquired platelet dysfunction. Hämostaseologie. 31(1). 28–40. 8 indexed citations
10.
Frieling, Thomas, Jürgen Homann, H.-J. Hertfelder, et al.. (2011). Evidence for Mast Cell Activation in Patients with Therapy-Resistant Irritable Bowel Syndrome. Zeitschrift für Gastroenterologie. 49(2). 191–194. 31 indexed citations
11.
Oldenburg, Johannes, Simone Rost, H. Seidel, Matthias Watzka, & C. Müller‐Reible. (2008). Pharmakogenetik der oralen Antikoagulation mit Cumarinen. Medizinische Genetik. 20(2). 230–235. 2 indexed citations
12.
Jönsson, Peter, Peter Höglund, Thomas Wiebe, et al.. (2007). Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia. Anti-Cancer Drugs. 18(8). 941–948. 12 indexed citations
13.
Skärby, Tor, H. Anderson, Jesper Heldrup, et al.. (2006). High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia. Leukemia. 20(11). 1955–1962. 90 indexed citations
14.
Seidel, H., Anders Andersen, Jan Terje Kvaløy, et al.. (2000). Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables. Leukemia Research. 24(3). 193–199. 29 indexed citations
15.
Seidel, H., Randi Nygaard, Peter Johan Moe, et al.. (1997). On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia. Leukemia Research. 21(5). 429–434. 18 indexed citations
16.
Seidel, H., et al.. (1994). Evaluation of Serious Adverse Events in Patients Treated with Protocols Including Methotrexate Infusions. Pediatric Hematology and Oncology. 11(2). 165–172. 24 indexed citations
17.
Kreuger, Anders, et al.. (1992). Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two cases. Acta Paediatrica. 81(4). 359–361. 29 indexed citations
18.
Emons, Hendrik, et al.. (1992). Voltammetric trace determination of ubiquinones at mercury electrodes. Analytical and Bioanalytical Chemistry. 342(9). 737–739. 9 indexed citations
19.
Seidel, H., et al.. (1988). Fully Enzymatic Colorimetric Assay of Serum and Urine Creatinine Which Obviates the Need for Sample Blank Measurements. Analytical Letters. 21(6). 1009–1017. 13 indexed citations
20.
Seidel, H., et al.. (1977). [Pharmacokinetics of methylmethacrylate monomer of bone cements: method for qualitative and quantitative monomer determination in respiratory air].. PubMed. 48(5). 316–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josef Häger Breakdown of academic impact, for papers by O’Neill Barrett Breakdown of academic impact, for papers by Harriet Hédin Breakdown of academic impact, for papers by H. Owen Breakdown of academic impact, for papers by Thomas D. Beardmore Breakdown of academic impact, for papers by Ryan J. Smith Breakdown of academic impact, for papers by J. Scharf Breakdown of academic impact, for papers by Gökhan Koca Breakdown of academic impact, for papers by Jorge A. Alvarez Breakdown of academic impact, for papers by Schmutz Jl
Rankless by CCL
2026